Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical Treatment of Migraines Clinical Study

NCT03902496 is registered in ClinicalTrials.gov with Avulux, Inc. as lead sponsor.

NCT NCT03902496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03902496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical Treatment of Migraines Clinical Study
Lead sponsor
Avulux, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 18, 2019
Completion date
May 17, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine